Welcome to LookChem.com Sign In|Join Free
  • or
Isoquinoline, 7-fluoro-3,4-dihydro-1-methyl- (9CI) is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

269402-41-7

Post Buying Request

269402-41-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

269402-41-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 269402-41-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,6,9,4,0 and 2 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 269402-41:
(8*2)+(7*6)+(6*9)+(5*4)+(4*0)+(3*2)+(2*4)+(1*1)=147
147 % 10 = 7
So 269402-41-7 is a valid CAS Registry Number.

269402-41-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 7-Fluoro-1-methyl-3,4-dihydro-isoquinoline

1.2 Other means of identification

Product number -
Other names 1-methyl-7-fluoro-3,4-dihydroisoquinoline

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:269402-41-7 SDS

269402-41-7Upstream product

269402-41-7Downstream Products

269402-41-7Relevant academic research and scientific papers

PYRAZOLOPYRIMIDINES HAVING ACTIVITY AGAINST THE RESPIRATORY SYNCYTIAL VIRUS (RSV)

-

Page/Page column 110; 111, (2019/06/17)

The invention concerns compounds having antiviral activity, in particular, having an inhibitory activity on the replication of the respiratory syncytial virus (RSV). The invention further concerns pharmaceutical compositions comprising these compounds and

Pyrimidine derivatives and processes for the preparation thereof

-

, (2008/06/13)

The present invention relates to novel pyrimidine derivatives and pharmaceutically acceptable non-toxic salts thereof which possess an excellent inhibitory activity against gastric acid secretion, a pharmaceutical composition containing the same as an active ingredient, and a process for the preparation thereof.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 269402-41-7